SH3BP5L Activators
SH3BP5 Activators are a diverse array of chemical compounds that indirectly enhance the functional activity of SH3BP5 through various signaling pathways. For instance, Forskolin, by increasing intracellular cAMP levels, could enhance SH3BP5 activity if it is regulated by cAMP-responsive pathways, with PKA potentially phosphorylating SH3BP5 to increase its activity.
Similar to Forskolin, 8-Br-cAMP, another cAMP analog, also activates PKA and could enhance SH3BP5 activity through the same mechanism. Ionomycin, through its action as a calcium ionophore, and Thapsigargin, by inhibiting SERCA, increase intracellular calcium levels, thereby activating calcium-dependent kinases that could enhance SH3BP5 activity if it is calcium/calmodulin-regulated. PMA and Sphingosine-1-phosphate operate through PKC and sphingosine-1-phosphate receptors respectively, both potentially enhancing SH3BP5 activity by activating downstream pathways such as PI3K/AKT, if SH3BP5 is a part of or regulated by these pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular levels of cAMP, which in turn activates PKA. PKA can phosphorylate various proteins, potentially enhancing the functional activity of SH3BP5L if it is a substrate or is regulated by PKA-dependent phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin serves as an ionophore for calcium, raising intracellular calcium levels and activating calcium-dependent signaling pathways. This could indirectly enhance the activity of SH3BP5L if it is sensitive to calcium-dependent regulatory mechanisms. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC) which is involved in numerous signaling pathways. PKC-mediated phosphorylation could enhance the functional activity of SH3BP5L if it is a substrate or is involved in PKC-regulated pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can engage multiple signaling pathways, including PI3K/AKT. This may lead to the functional activation of SH3BP5L if it participates in or is modulated by these pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate is a catechin with antioxidant properties and has been shown to inhibit certain protein kinases. Inhibition of competitive kinase signaling might enhance pathways in which SH3BP5L is involved, leading to its functional activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter the PI3K/AKT signaling pathway. If SH3BP5L activity is regulated in a PI3K/AKT-dependent manner, this compound could lead to its functional activation by modifying the pathway. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels and activation of calcium-dependent signaling. This could indirectly enhance the activity of SH3BP5L if it is modulated by calcium signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK, which can modulate the p38 MAPK signaling pathway. If SH3BP5L is implicated in this pathway, SB203580 could enhance its functional activity by altering p38 MAPK signaling. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates PKA. This compound could enhance the functional activity of SH3BP5L by PKA-mediated phosphorylation if SH3BP5L is regulated by cAMP/PKA signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. Although generally inhibitory, it may lead to selective activation of SH3BP5L pathways by inhibiting kinases that negatively regulate SH3BP5L. | ||||||